Plunkett Research Online: Adaptimmune Therapeutics plc

ADAPTIMMUNE THERAPEUTICS PLC (ADAP) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell r.....


ADAPTIMMUNE THERAPEUTICS PLC

Ticker: ADAP
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 44 1235430000
Fax: 44 1235430001
Address: 60 Jubilee Avenue
Abingdon, Oxfordshire OX14 4RY United Kingdom

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Adrian RawcliffeCEO/Director
Gavin WoodCFO/Chief Accounting Officer
See More
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell r.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture